top
Search terms
Results 1 - 10 of 16 - ordered by :
Pages: 1 2
Eurointervention

EuroIntervention Novel oral anticoagulants in acute coronary syndrome: re-evaluating the thrombin hypothesis Department of Cardiology, EA3920, University Hospital Jean Minjoz, Besançon, France ...

Date : 20/03/2014 Item size : 32584 bytes
Eurointervention

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. Dewilde W., Ten Berg JM, Trial design: WOEST Trial: What is the Optimal antiplatElet & ...

Date : 15/01/2010 Item size : 35995 bytes
Epeuropace

The survey highlights two important areas of uncertainty regarding the optimal composition and duration of antithrombotic therapy with multiple drugs and the optimal regimen(s) of novel oral ...

Europace, EP WIRE, Tatjana S. Potpara, Gregory Y. H. Lip, Nikolaos Dagres, Heidi L. Estner, Torben B. Larsen, Carina Blomström-Lundqvist, Conducted by the Scientific Initiatives Committee, ...

Date : 01/02/2014 Item size : 169825 bytes
Epeuropace

Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey Abstract The ...

Europace, EP WIRE, Torben Bjerregaard Larsen, Tatjana Potpara, Nikolaos Dagres, Alessandro Proclemer, Elena Sciarrafia, Carina Blomström-Lundqvist

Date : 01/05/2015 Item size : 161520 bytes
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Ehjournal

In the last two centuries, with an ageing population and the advance of atherosclerosis, an overly active coagulation system has become a liability for the older individual because it can lead to ...

European Heart Journal, Moser, Martin, Bode, Christoph

Date : 01/11/2011 Item size : 130701 bytes
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes
Ehjournal

Conclusion In patients with a recent acute coronary syndrome, the addition of a new oral anticoagulant to antiplatelet therapy results in a modest reduction in cardiovascular events but a substantial ...

European Heart Journal, Oldgren, Jonas, Wallentin, Lars, Alexander, John H., James, Stefan, Jönelid, Birgitta, Steg, Gabriel, Sundström, Johan

Date : 07/06/2013
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 490669 bytes
Ehjournal

In the last two centuries, with an ageing population and the advance of atherosclerosis, an overly active coagulation system has become a liability for the older individual because it can lead to ...

European Heart Journal, Moser, Martin, Bode, Christoph

Date : 01/11/2011 Item size : 138201 bytes